Dehydroascorbic acid irreversibly inhibits hexokinase activity

被引:40
作者
Fiorani, M [1 ]
De Sanctis, R [1 ]
Scarlatti, F [1 ]
Vallorani, L [1 ]
De Bellis, R [1 ]
Serafini, G [1 ]
Bianchi, M [1 ]
Stocchi, V [1 ]
机构
[1] Ist Chim Biol Giorgio Fornaini, I-61029 Urbino, PU, Italy
关键词
hexokinase; dehydroascorbic acid; thiol groups; protein modification;
D O I
10.1023/A:1007168032289
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The oxidized form of vitamin C (dehydroascorbic acid, DHA) completely and irreversibly inactivates recombinant human hexokinase type I, in a pseudo-first order fashion. The inactivation reaction occurs without saturation, indicating that DHA does not form a reversible complex with hexokinase. Further characterization of this response revealed that the inactivation does not require oxygen and that dithiothreitol, while able to prevent the DHA-mediated loss of enzyme activity, failed to restore the activity of the DHA-inhibited enzyme. Inactivation was not associated with cleavage of the peptide chain or cross-linking. The decay in enzymatic activity was however both dependent on deprotonation of a residue with an alkaline pK(a) and associated with covalent binding of DHA to the protein. In addition, inactivation of hexokinase decreased or increased, respectively, in the presence of the substrates glucose or MgATP. Finally, amino acid analysis of the DHA-modified hexokinase revealed a decrease of cysteine residues. Taken together, the above results are consistent with the possibility that covalent binding of the reagent with a thiol group of cysteine is a critical event for the DHA-mediated loss of hexokinase activity.
引用
收藏
页码:145 / 153
页数:9
相关论文
共 53 条
[1]   Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transporters [J].
Agus, DB ;
Gambhir, SS ;
Pardridge, WM ;
Spielholz, C ;
Baselga, J ;
Vera, JC ;
Golde, DW .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (11) :2842-2848
[2]  
AMICI A, 1989, J BIOL CHEM, V264, P3341
[3]   Dehydroascorbate and ascorbate transport in rat liver microsomal vesicles [J].
Bánhegyi, G ;
Marcolongo, P ;
Puskás, F ;
Fulceri, R ;
Mandl, J ;
Benedetti, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (05) :2758-2762
[4]  
BEUTLER E, 1984, RED BLOOD CELL METAB
[5]   DEHYDROASCORBIC ACID AND CELL-MEMBRANES - POSSIBLE DISRUPTIVE EFFECTS [J].
BIANCHI, J ;
ROSE, RC .
TOXICOLOGY, 1986, 40 (01) :75-82
[6]   Enzymatic properties of overexpressed human hexokinase fragments [J].
Bianchi, M ;
Serafini, G ;
Bartolucci, E ;
Giammarini, C ;
Magnani, M .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1998, 189 (1-2) :185-193
[7]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[8]   ESTIMATION OF DEHYDROASCORBIC ACID IN BLOOD OF DIABETIC-PATIENTS [J].
CHATTERJEE, IB ;
BANERJEE, A .
ANALYTICAL BIOCHEMISTRY, 1979, 98 (02) :368-374
[9]   STUDY OF SULFHYDRYL GROUPS OF RAT-BRAIN HEXOKINASE [J].
CHOU, AC ;
WILSON, JE .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1974, 163 (01) :191-199
[10]  
DAVIES K J A, 1986, Journal of Free Radicals in Biology and Medicine, V2, P155, DOI 10.1016/S0748-5514(86)80066-6